GLENMARK THERAPEUTICS Trademark

Trademark Overview

On Monday, April 4, 2022, a trademark application was filed for GLENMARK THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the GLENMARK THERAPEUTICS trademark a serial number of 97976501. The federal status of this trademark filing is REGISTERED as of Tuesday, February 27, 2024. This trademark is owned by Glenmark Therapeutics Inc., USA. The GLENMARK THERAPEUTICS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, contraceptive preparations; pharmaceutical preparations, namely, antacids, acid reducers for the management of heartburn
glenmark therapeutics

General Information

Serial Number97976501
Word MarkGLENMARK THERAPEUTICS
Filing DateMonday, April 4, 2022
Status700 - REGISTERED
Status DateTuesday, February 27, 2024
Registration Number7317749
Registration DateTuesday, February 27, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 20, 2022

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, contraceptive preparations; pharmaceutical preparations, namely, antacids, acid reducers for the management of heartburn
NOT AVAILABLE"THERAPEUTICS"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, April 8, 2022
Primary Code005
First Use Anywhere DateWednesday, July 6, 2022
First Use In Commerce DateMonday, August 1, 2022

Trademark Owner History

Party NameGlenmark Therapeutics Inc., USA
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressMahwah, NJ 07430
Party NameGlenmark Therapeutics Inc., USA
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMahwah, NJ 07430
Party NameGlenmark Therapeutics Inc., USA
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMahwah, NJ 07430

Trademark Events

Event DateEvent Description
Thursday, May 12, 2022NON-FINAL ACTION WRITTEN
Thursday, April 7, 2022NEW APPLICATION ENTERED
Friday, April 8, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, May 11, 2022ASSIGNED TO EXAMINER
Thursday, May 12, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, May 12, 2022NON-FINAL ACTION E-MAILED
Friday, July 22, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, July 22, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, July 22, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, August 17, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 31, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 20, 2022PUBLISHED FOR OPPOSITION
Tuesday, September 20, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 15, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, January 18, 2023TEAS STATEMENT OF USE RECEIVED
Thursday, February 16, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, March 27, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, January 18, 2023USE AMENDMENT FILED
Thursday, February 16, 2023STATEMENT OF USE PROCESSING COMPLETE
Monday, March 27, 2023SU - NON-FINAL ACTION - WRITTEN
Monday, March 27, 2023NON-FINAL ACTION E-MAILED
Wednesday, May 3, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, May 3, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, May 3, 2023DIVISIONAL REQUEST RECEIVED
Wednesday, May 3, 2023TEAS REQUEST TO DIVIDE RECEIVED
Thursday, May 4, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, May 26, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, August 31, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, September 18, 2023DIVISIONAL PROCESSING COMPLETE
Friday, December 15, 2023SU - NON-FINAL ACTION - WRITTEN
Friday, December 15, 2023NON-FINAL ACTION E-MAILED
Friday, December 15, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, January 24, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, January 25, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, February 27, 2024REGISTERED-PRINCIPAL REGISTER
Monday, May 19, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, May 19, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, May 19, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, May 19, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, May 19, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, February 27, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED

Related Keywords

therapeutics glenmark preparations pharmaceutical namely management reducers heartburn antacids contraceptive acid